Skip to main content
. 2018 Jul 24;73(10):2721–2728. doi: 10.1093/jac/dky256

Figure 3.

Figure 3.

Multiple sequence alignment and genotypic resistance prediction. (a) Multiple sequence alignment of the clinical isolates from treatment-failure patients. HXB2 was used as reference. The DRM positions are shaded. (b) Genotypic resistance prediction of the clinical isolates in the Stanford HIV drug resistance database. ABC, abacavir; ZDV, zidovudine, d4T, stavudine; FTC, emtricitabine; 3TC, lamivudine; TDF, tenofovir disoproxil fumarate; EFV, efavirenz; ETR, etravirine; NVP, nevirapine; RPV, rilpivirine.